Voyager Therapeutics (VYGR) Preferred Dividend Payments (2014 - 2015)
Voyager Therapeutics (VYGR) reported Preferred Dividend Payments of $1.3 million for Q4 2015, up 161.93% on a YoY basis from $507000.0 in Q4 2014, and down 48.8% sequentially from $2.6 million in Q3 2015.
Voyager Therapeutics (VYGR) Preferred Dividend Payments (2014 - 2015) Analysis & Trends
Voyager Therapeutics (VYGR) has 2 years of Preferred Dividend Payments data on file, last reported at $1.3 million in Q4 2015.
- For the quarter ending Q4 2015, Preferred Dividend Payments rose 161.93% year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2015 stood at $5.3 million (changed N/A YoY), and the FY2016 full-year result was $1.2 million, down 83.72% from the prior year.
- Preferred Dividend Payments declined to $1.3 million in Q4 2015, from $2.6 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $2.6 million in Q3 2015 to a low of $399000.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Voyager Therapeutics | 184.74 Mn | 43.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 1.33 Mn |
| Sep 30, 2015 | 2.59 Mn |
| Jun 30, 2015 | 399,000.00 |
| Mar 31, 2015 | 999,000.00 |
| Dec 31, 2014 | 507,000.00 |
| Sep 30, 2014 | 406,000.00 |